Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Frevecitinib by Kinaset Therapeutics for Chronic Obstructive Pulmonary Disease (COPD): Likelihood of Approval
Frevecitinib is under clinical development by Kinaset Therapeutics and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD). According...
Data Insights
Frevecitinib by Kinaset Therapeutics for Asthma: Likelihood of Approval
Frevecitinib is under clinical development by Kinaset Therapeutics and currently in Phase I for Asthma. According to GlobalData, Phase I...